PubMed:32845588
Annnotations
luoyt2021_800_3
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 5-14 | DP | denotes | Psoriasis |
| T10 | 500-509 | DP | denotes | psoriasis |
| T11 | 456-465 | DP | denotes | psoriasis |
| T12 | 351-360 | DP | denotes | psoriasis |
| T13 | 259-268 | DP | denotes | psoriasis |
| T14 | 169-178 | DP | denotes | psoriasis |
| T15 | 135-144 | DP | denotes | psoriasis |
| T16 | 95-104 | DP | denotes | Psoriasis |
| T17 | 1639-1649 | CI | denotes | ixekizumab |
| T18 | 1530-1540 | CI | denotes | ixekizumab |
| T19 | 1447-1457 | CI | denotes | ixekizumab |
| T2 | 1563-1572 | DP | denotes | psoriasis |
| T20 | 1330-1340 | CI | denotes | ixekizumab |
| T21 | 1161-1171 | CI | denotes | ixekizumab |
| T22 | 701-711 | CI | denotes | ixekizumab |
| T23 | 422-432 | CI | denotes | ixekizumab |
| T24 | 48-58 | CI | denotes | Ixekizumab |
| T25 | 677-684 | CI | denotes | placebo |
| T3 | 1502-1511 | DP | denotes | psoriasis |
| T4 | 1387-1396 | DP | denotes | psoriasis |
| T5 | 1245-1254 | DP | denotes | psoriasis |
| T6 | 1137-1146 | DP | denotes | psoriasis |
| T7 | 932-941 | DP | denotes | Psoriasis |
| T8 | 795-804 | DP | denotes | Psoriasis |
| T9 | 746-755 | DP | denotes | psoriasis |
| T26 | 1176-1186 | CI | denotes | etanercept |
| T27 | 686-696 | CI | denotes | etanercept |
Linmchun_800_3
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 95-104 | DP | denotes | Psoriasis |
| T10 | 795-804 | DP | denotes | Psoriasis |
| T11 | 932-941 | DP | denotes | Psoriasis |
| T12 | 1137-1146 | DP | denotes | psoriasis |
| T13 | 1245-1254 | DP | denotes | psoriasis |
| T14 | 1387-1396 | DP | denotes | psoriasis |
| T15 | 1563-1572 | DP | denotes | psoriasis |
| T16 | 1502-1511 | DP | denotes | psoriasis |
| T17 | 1330-1340 | CI | denotes | ixekizumab |
| T18 | 1447-1457 | CI | denotes | ixekizumab |
| T19 | 48-58 | CI | denotes | Ixekizumab |
| T2 | 5-14 | DP | denotes | Psoriasis |
| T20 | 422-432 | CI | denotes | ixekizumab |
| T21 | 701-711 | CI | denotes | ixekizumab |
| T22 | 1161-1171 | CI | denotes | ixekizumab |
| T23 | 1530-1540 | CI | denotes | ixekizumab |
| T24 | 1639-1649 | CI | denotes | ixekizumab |
| T25 | 677-684 | CI | denotes | placebo |
| T26 | 686-696 | CI | denotes | etanercept |
| T3 | 135-144 | DP | denotes | psoriasis |
| T4 | 169-178 | DP | denotes | psoriasis |
| T5 | 259-268 | DP | denotes | psoriasis |
| T6 | 456-465 | DP | denotes | psoriasis |
| T7 | 351-360 | DP | denotes | psoriasis |
| T8 | 500-509 | DP | denotes | psoriasis |
| T9 | 746-755 | DP | denotes | psoriasis |
| T27 | 1176-1186 | CI | denotes | etanercept |